RSPH3
Radial spoke head protein 3 homolog
Also known as: RSPH3_HUMAN
Protein identityUniProt · HPA
- UniProt accession
- Q86UC2
- Gene
- RSPH3
- Canonical length
- 560 aa
- Protein class
- Human disease related genes, Predicted intracellular proteins
OverviewNCBI Gene
No narrative summary is available for RSPH3 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
560 residues, UniProt reviewed canonical sequence.
>Q86UC2|RSPH3
1 MTVKPAKAAS LARNLAKRRR TYLGGAAGRS QEPEVPCAAV LPGKPGDRNC PEFPPPDRTL
61 GCWATDAAPA AGLCGAGSEP SIAPTSCAGN LPSRPPPLLS PLLASRNPCP WHYLHLSGSH
121 NTLAPTCFKA KLHRKRGSQP PDMASALTDR TSRAPSTYTY TSRPRALPCQ RSRYRDSLTQ
181 PDEEPMHYGN IMYDRRVIRG NTYALQTGPL LGRPDSLELQ RQREARKRAL ARKQAQEQLR
241 PQTPEPVEGR KHVDVQTELY LEEIADRIIE VDMECQTDAF LDRPPTPLFI PAKTGKDVAT
301 QILEGELFDF DLEVKPVLEV LVGKTIEQSL LEVMEEEELA NLRASQREYE ELRNSERAEV
361 QRLEEQERRH REEKERRKKQ QWEIMHKHNE TSQKIAARAF AQRYLADLLP SVFGSLRDSG
421 YFYDPIERDI EIGFLPWLMN EVEKTMEYSM VGRTVLDMLI REVVEKRLCM YEHGEDTHQS
481 PEPEDEPGGP GAMTESLEAS EFLEQSMSQT RELLLDGGYL QRTTYDRRSS QERKFMEERE
541 LLGQDEETAM RKSLGEEELSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RSPH3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.63
- Highest tissue expression
- 12 nTPM
Expression across tissuesHPA
Tissue
- parathyroid gland: 12 nTPM
- testis: 12 nTPM
- choroid plexus: 8.4 nTPM
- thyroid gland: 7 nTPM
- esophagus: 6.2 nTPM
- retina: 6.1 nTPM
Single-cell type
- respiratory ciliated cells: 313 nCPM
- endometrial ciliated cells: 206 nCPM
- esophageal apical cells: 188 nCPM
- ependymal cells: 176 nCPM
- choroid plexus epithelial cells: 161 nCPM
- late primary spermatocytes: 151 nCPM
Immune cell
- neutrophil: 11 nTPM
- non-classical monocyte: 7 nTPM
- plasmacytoid DC: 4.6 nTPM
- classical monocyte: 4 nTPM
- myeloid DC: 4 nTPM
- intermediate monocyte: 3 nTPM
Brain region
- choroid plexus: 41 nTPM
- cerebral cortex: 20 nTPM
- midbrain: 15 nTPM
- medulla oblongata: 14 nTPM
- hippocampal formation: 14 nTPM
- spinal cord: 13 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about RSPH3.
Disease | AllUniProt
Conditions RSPH3 is implicated in, by any mechanism.
- Ciliary dyskinesia, primary, 32 (CILD32) MIM:616481
Disease | GeneticClinVar
30 pathogenic / likely-pathogenic of 357 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Primary ciliary dyskinesia 32
- RSPH3-related disorder
- Clear cell carcinoma of kidney
- Colon adenocarcinoma
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.93
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.07
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Radial spoke 3
- Radial spoke protein 3
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RSPH3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RSPH3 as an antibody target. Whether an autoantibody or antibody against RSPH3 could matter depends on whether native RSPH3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RSPH3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RSPH3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...